Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone and Lifestyle Therapy in Obese Older Veterans
NCT02367105Phase 3Completed
- Sponsor
- VA Office of Research & Development
- Start
- Feb 2015
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Testosterone TEPI patch in Hypogonadism (2 arms), sponsored by VA Office of Research & Development. Primary endpoint: Physical Performance Test at 6 months. Started Feb 2015; status: completed.
02
Drugs
Testosterone TEPI patch
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT02367105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02367105.